Shay Capital’s OncoSec Medical Incorporated ONCS Stock Holding History

Shay Capital’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,139	Closed	-$70K	–	787
2021 Q2	$70K	Buy	+1,139	New	+$103K	0.01%	483

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shay Capital's ONCS Position: Q3 2021 in Review

Shay Capital sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 1,139 shares — an estimated $70K sold.

Shay Capital first reported a position in ONCS in Q2 2021 and held it in 1 quarter. The position peaked at $70K in Q2 2021. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

Shay Capital reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
Shay Capital sold 1,139 OncoSec Medical Incorporated shares in Q3 2021, an estimated $70K.
Shay Capital first reported a position in OncoSec Medical Incorporated in Q2 2021 and held it in 1 quarter.
Shay Capital's OncoSec Medical Incorporated position peaked at $70K in Q2 2021.
31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Shay Capital's 13F filing for Q3 2021, filed 15 Nov 2021.